CORONA Remedies Limited (NSE:CORONA)

Market Cap	106.77B
Revenue (ttm)	13.44B +32.5%
Net Income	1.71B +89.3%
EPS	28.02 +89.4%
Shares Out	61.16M
PE Ratio	62.31
Forward PE	45.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,757
Average Volume	30,269
Open	1,775.00
Previous Close	1,760.80
Day's Range	1,736.00 - 1,790.00
52-Week Range	1,336.60 - 1,786.60
Beta	n/a
RSI	68.89
Earnings Date	May 11, 2026

About CORONA Remedies

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 4,500
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CORONA

Financial Performance

In fiscal year 2025, CORONA Remedies's revenue was 11.96 billion, an increase of 17.93% compared to the previous year's 10.14 billion. Earnings were 1.49 billion, an increase of 65.11%.